リコンビナント
RabMAb

Anti-FADD 抗体 [EPR5030] (ab124812)

ab124812 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab124812 は 4 報の論文で使用されています。

  • Wang JB  et al. A systems pharmacology-oriented discovery of a new therapeutic use of the TCM formula Liuweiwuling for liver failure. Sci Rep 8:5645 (2018). PubMed: 29618826
  • Geng J  et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun 8:359 (2017). PubMed: 28842570
  • Bowman BM  et al. Phosphorylation of FADD by the kinase CK1a promotes KRASG12D-induced lung cancer. Sci Signal 8:ra9 (2015). PubMed: 25628462
  • Jaiswal MK  et al. Regulation of apoptosis and innate immune stimuli in inflammation-induced preterm labor. J Immunol 191:5702-13 (2013). WB, IHC-Fr ; Mouse . PubMed: 24163412

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録